“Pharmaceutical Attention in the Treatment of Obesity Involving Analogues of Glucagon-Like Peptide 1 (GPL-1)”. 2022. Research, Society and Development 11 (7): e41011730134. https://doi.org/10.33448/rsd-v11i7.30134.